Pilulka Lekarny as Net Assets

Latest as of : Kč- CZK ≈ $- USD

Pilulka Lekarny as net assets. Based on the latest financial reports, Pilulka Lekarny as (PINK) has net assets worth Kč- CZK (≈ $- USD) as of . Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Kč- ≈ $- USD) and total liabilities (Kč- ≈ $- USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See Pilulka Lekarny as (PINK) net asset quality to measure how much of total assets are equity-financed.

Key Net Assets Metrics

Metric Value
Current Net Assets Kč-
% of Total Assets 0%
Annual Growth Rate N/A
5-Year Change -144.37%
10-Year Change N/A
Growth Volatility 193.37

Net Assets of Pilulka Lekarny as (2018–2024)

Net assets of Pilulka Lekarny as from 2018 to 2024. This chart illustrates how Pilulka Lekarny as's net assets have evolved over time, based on quarterly financial data. Also explore PINK year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Annual Net Assets for Pilulka Lekarny as (2018–2024)

The table below shows the annual net assets of Pilulka Lekarny as from 2018 to 2024. For live market cap and overall valuation, see Pilulka Lekarny as stock valuation.

Year Net Assets Change
2024-12-31 Kč-96.75 Million
≈ $-4.64 Million
-415.07%
2023-12-31 Kč30.71 Million
≈ $1.47 Million
-77.90%
2022-12-31 Kč138.93 Million
≈ $6.66 Million
-31.93%
2021-12-31 Kč204.10 Million
≈ $9.79 Million
-6.40%
2020-12-31 Kč218.06 Million
≈ $10.46 Million
+170.23%
2019-12-31 Kč80.69 Million
≈ $3.87 Million
+152.37%
2018-12-31 Kč31.97 Million
≈ $1.53 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Pilulka Lekarny as's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 50298000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Pilulka Lekarny as Net Assets Breakdown (December 2024)

Pilulka Lekarny as net assets breakdown by equity component as of December 2024.

Component Amount Percentage
Other Components Kč458.62 Million %
Total Equity Kč-93.97 Million 100.00%

Pilulka Lekarny as Competitors by Market Cap

The table below lists competitors of Pilulka Lekarny as ranked by their market capitalization.

Company Market Cap
Thai Wire Products Public Company Limited
BK:TWP
$11.82 Million
Legend Power Systems Inc
V:LPS
$11.82 Million
Sambhaav Media Limited
NSE:SAMBHAAV
$11.82 Million
Schroder Oriental Income Fund
LSE:SOI
$11.83 Million
Western Resources Corp
TO:WRX
$11.81 Million
LIFESPEAK INC.
F:81F
$11.80 Million
SILVER DOLLAR RES
F:4YW
$11.80 Million
Aelis Farma SA
PA:AELIS
$11.79 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Pilulka Lekarny as's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 32,846,000 to -93,975,000, a change of -126,821,000 (-386.1%).
  • Net loss of 125,743,000 reduced equity.
  • Other factors decreased equity by 1,078,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income Kč-125.74 Million -133.8%
Other Changes Kč-1.08 Million -1.15%
Total Change Kč- -386.11%

Book Value vs Market Value Analysis

This analysis compares Pilulka Lekarny as's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2018-12-31 Kč13.08 Kč91.00 x
2019-12-31 Kč34.62 Kč91.00 x
2020-12-31 Kč90.17 Kč91.00 x
2021-12-31 Kč80.90 Kč91.00 x
2022-12-31 Kč55.01 Kč91.00 x
2023-12-31 Kč12.13 Kč91.00 x
2024-12-31 Kč-34.72 Kč91.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Pilulka Lekarny as utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -9.64%
  • • Asset Turnover: 5.50x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-104.57%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2018 -78.18% -2.53% 3.22x 9.57x Kč-28.83 Million
2019 -50.49% -3.32% 3.35x 4.55x Kč-52.35 Million
2020 -11.26% -1.44% 3.57x 2.19x Kč-48.42 Million
2021 -12.56% -1.08% 4.04x 2.88x Kč-46.11 Million
2022 -46.92% -2.69% 4.04x 4.32x Kč-79.77 Million
2023 -532.62% -8.21% 4.85x 13.39x Kč-178.23 Million
2024 0.00% -9.64% 5.50x 0.00x Kč-116.35 Million

Industry Comparison

This section compares Pilulka Lekarny as's net assets metrics with peer companies in the Pharmaceutical Retailers industry.

No peer company data available for comparison.

About Pilulka Lekarny as

PR:PINK Czech Republic Pharmaceutical Retailers
Market Cap
$11.81 Million
Kč246.31 Million CZK
Market Cap Rank
#26554 Global
#18 in Czech Republic
Share Price
Kč91.00
Change (1 day)
+0.00%
52-Week Range
Kč90.00 - Kč186.00
All Time High
Kč1800.00
About

Pilulka Lékárny a.s. operates a network of pharmacy stores under the Pilulka brand in the Czech Republic, Slovakia, Romania, Hungary, and Austria. The company distributes medicinal products; online sale of pharmacy and related goods for health; and healthy lifestyle and services under the Pilulka brand. It also operates Internet portals, such as Pilulka.cz, Pilulka.sk, Pilulka.ro, Pilulka.hu, and… Read more